Clear Regulatory Framework for Hemp and Hemp-derived CBD Products Urged in Bill H.R. 841
EAS is closely monitoring progress of bi-partisan legislation introduced to the 117th Congress on February 4, 2021, H.R. 841, the Hemp and Hemp-derived CBD Consumer Protection and Market Stabilization Act of 2021. The bill seeks a federal regulatory framework for hemp...
EAS Senior Director Tara Lin Couch, Ph.D. Featured in NCIA Podcast on the Future of Cannabis Consumerism
EAS Senior Director for Dietary Supplement and Tobacco Services, Tara Lin Couch, Ph.D. was interviewed for the National Cannabis Business Industry’s podcast on the future of cannabis consumerism. Listen now on Apple podcast and Stitcher and hear more about the...
GMPs for Hemp and CBD?
Developing solid GMP protocols is essential for firms operating in the hemp and CBD space. Read EAS independent consultant Charlotte Peyton’s blog published on the National Cannabis Business Industry (NCIA)’s website. Join EAS for our upcoming EAS short course on...
House Vote on Legalization of Marijuana Delayed
Of interest to the hemp, CBD and cannabis industries, the US House Democratic leaders have decided to postpone voting on legislation to decriminalize marijuana at the federal level until after the November 3, 2020 election. EAS team of consultants, under leadership of...
Developing Quality Systems for the CBD and Hemp Industries – EAS Short Course
As states begin to regulate legalized CBD and hemp, the concern of how Good Manufacturing Practices (GMPs) apply to these unique industries cannot be understated. While regulations vary from state to state the quality systems under which products are grown …